Revenue Cycle Management

Specialized laboratory revenue cycle.

Diagnostic revenue cycle is not general healthcare RCM. DMC works specifically around molecular, anatomic pathology, toxicology, and genomics economics — where claims fail for reasons generic billing operations rarely diagnose.

Context, not just claims
We understand the reimbursement and scientific context behind the claim — not only the billing transaction.
Assay-level specificity
Coding, documentation, and payer policy handled per assay rather than per generic service line.
Senior accountability
Escalations reviewed by people who have built reimbursement strategy, not only processed claims.
Capabilities

A complete revenue cycle stack.

  • 01

    Prior Authorization

    Payer-specific PA and medical-necessity workflows, supported by automation where it reduces manual burden.
  • 02

    Coding integrity

    CPT, PLA, HCPCS, modifier, Z-code, and CCI logic tuned to the specific assays in your menu, with pre-submission claim scrubbing.
  • 03

    Denials & appeals

    Root-cause review and payer-by-payer appeal workflows built around diagnostic coverage policy language.
  • 04

    Managed Care Contracting

    Contract strategy, negotiation, and modeling with commercial payers, Medicare Advantage, and Medicaid managed care.
  • 05

    Reconciliation & analytics

    Payment posting, reconciliation, and net revenue per test, per payer, and per assay with variance review.
Begin the conversation

Tell us where reimbursement is breaking down.